Clinical trial
Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in…
NCT00144430 · Ann & Robert H Lurie Children's Hospital of Chicago, Other · Completed
Key facts
| NCT number | NCT00144430 |
|---|---|
| Title | Pentostatin for High Risk and Refractory Chronic Graft Versus Host Disease in Children |
| Official title | A Phase II Study of Pentostatin For the Treatment of High Risk or Refractory Chronic GVHD in Children |
| Lead sponsor | Ann & Robert H Lurie Children's Hospital of Chicago, Other |
| Collaborators | Astex Pharmaceuticals, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Graft vs Host Disease |
| Intervention type | Drug |
| Interventions | Pentostatin |
| Enrollment | 60 |
| Start date | Jan 1, 2004 |
| Primary completion | Aug 1, 2008 |
| Completion | Aug 1, 2008 |
| First posted | Sep 5, 2005 |
| Last update posted | Feb 3, 2009 |
| Countries | United States |
At a glance
- 10–99 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: